INTRODUC

ADVANCES OF LABORATORY DIAGNOSTICS.
Molecular screening methods can complement conventional culture, antigen and antibody-based methods for the detection, identification and epidemiologic analysis of infectious microorganisms. The role of molecular detection and fingerprinting of microorganisms has shifted gradually from the academic world to the routine diagnostic laboratory and have been used increasingly over the past decade to improve the sensitivity, specificity and time performing in the clinical laboratory. Moreover, many high-throughput molecular tests are now available commercially, which impacts on the infrastructure in many of the diagnostic laboratories.
The new diagnostic tools are the most changing and developing part of Chlamydia and HPV national strategies. The role of molecular detection such as nucleic acid amplification tests (NAATs) and fingerprinting of microorganisms has shifted gradually from the academic world to the routine diagnostic laboratory and have been used increasingly over the past decade to improve the sensitivity, specificity and time performing in the clinical laboratory. Despite the advantages and popularity of molecular diagnostic and fingerprinting methods, significant challenges must be addressed before these methods can be adopted in the clinical diagnostic laboratory. Sequence-based identification and strain typing, along with the development of probes for genetic markers, allows detailed strain fingerprinting. DNA fingerprint analysis can be used to study strain relatedness, as well as group heterogeneity for a particular organism. Thus, analysis can have a significant impact on patient management and disease control through early detection of disease clusters or outbreaks. This molecular typing has added a new dimension to studying the epidemiology of communicable diseases and the quantification of the extent of transmission. Standard genotyping methods require either highly discriminative but heavy, and relatively expensive devices such as automated capillary electrophoresis devices, or cheaper, easy to use but more time consuming and with lower resolution power such as agarose gels. The new miniaturized platforms based on microfluidic nanotechnology for quantification and separation of nucleic acid molecules have shown accuracy, precision and high feasibility along with speed and moderate cost reagents.
EUROPEAN CONFERENCE OF NATIONAL STRATEGIES FOR CHLAMYDIA TRACHOMATIS AND HUMAN PAPILLOMAVIRUS
Purpose of the Conference is to provide guidance in the European Union about national strategies for Chlamydia trachomatis and HPV early detection and control. It will provide a framework for developing, implementing or improving national strategies to control of Chlamydia trachomatis and HPV. 
